Preferred Label : insulin degludec;
MeSH synonym : degludec; (1A-21A),(1B-29B)-insulin (human), 29B-(N6-(N-(15-carboxy-1- oxopentadecyl)-L-gamma-
glutamyl)-L-lysine)-;
Is substance : O;
UNII : 54Q18076QB;
Origin ID : C571886;
UMLS CUI : C3491971;
ATC code(s)
- CISMeF manual mappings
- MeSH term(s) associated for indexing
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/insuline-degludec
2022
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
insulin, long-acting
---
https://www.louvainmedical.be/fr/article/degludec-tresibar-un-nouvel-analogue-dinsuline-basale-action-ultra-longue
2019
false
false
false
Belgium
insulin degludec
diabetes mellitus, type 1
diabetes mellitus, type 2
hypoglycemia
Glycated Hemoglobin
blood glucose
treatment outcome
journal article
insulin, long-acting
---
Progrès thérapeutique mineur en termes de tolérance par rapport à LANTUS, chez les
adultes diabétiques de type 1 ou 2, à haut risque d’hypoglycémie.
https://www.has-sante.fr/portail/jcms/c_2906439/fr/tresiba
https://www.has-sante.fr/portail/jcms/c_2906439/fr/tresiba-insuline-degludec-analogue-lent-de-l-insuline
2019
false
true
false
false
France
French
evaluation of the transparency committee
injections, subcutaneous
hypoglycemic agents
insurance, health, reimbursement
adult
diabetes mellitus, type 1
diabetes mellitus, type 2
insulin degludec
insulin degludec
treatment outcome
aged
cardiovascular diseases
hypoglycemia
guidelines for drug use
insulin, long-acting
---
https://pharmactuel.com/index.php/pharmactuel/article/view/1235
2019
false
false
false
false
France
comparative effectiveness research
hypoglycemic agents
hypoglycemic agents
insulin degludec
Insulin Glargine
cardiovascular diseases
hypoglycemia
diabetes mellitus, type 2
critical appraisal or critical reading
insulin degludec
diabetes mellitus, type 2
Insulin Glargine
insulin, long-acting
insulin, long-acting
---
https://www.has-sante.fr/portail/jcms/c_2756350/fr/xultophy-insuline-degludec/liraglutide-antidiabetique
https://www.has-sante.fr/portail/jcms/c_2756350/fr/xultophy
2017
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
insulin degludec and liraglutide
insulin degludec
treatment outcome
insurance, health, reimbursement
hypoglycemic agents
incretins
diabetes mellitus, type 2
adult
drug therapy, combination
injections, subcutaneous
Liraglutide
guidelines for drug use
insulin, long-acting
---
https://www.has-sante.fr/portail/jcms/c_2818001/fr/xultophy-insuline-degludec/liraglutide-antidiabetique
https://www.has-sante.fr/portail/jcms/c_2818001/fr/xultophy
2017
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
insulin degludec and liraglutide
insulin degludec
treatment outcome
insurance, health, reimbursement
hypoglycemic agents
incretins
diabetes mellitus, type 2
adult
injections, subcutaneous
Liraglutide
guidelines for drug use
comparative effectiveness research
insulin, long-acting
---
http://www.has-sante.fr/portail/jcms/c_2607357/fr/xultophy
http://www.has-sante.fr/portail/jcms/c_2607357/fr/xultophy-insuline-degludec/liraglutide-antidiabetique
2016
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
insulin degludec and liraglutide
insulin degludec
treatment outcome
insurance, health, reimbursement
hypoglycemic agents
incretins
diabetes mellitus, type 2
adult
drug therapy, combination
injections, subcutaneous
Liraglutide
guidelines for drug use
insulin, long-acting
---
https://www.ema.europa.eu/medicines/human/EPAR/XULTOPHY
2014
false
true
false
false
United Kingdom
French
English
drug combinations
insulin degludec and liraglutide
insulin degludec
treatment outcome
hypoglycemic agents
incretins
diabetes mellitus, type 2
adult
drug therapy, combination
injections, subcutaneous
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug approval
europe
drug interactions
pregnancy
breast feeding
insulin degludec
incretins
hypoglycemic agents
Liraglutide
Liraglutide
insulin, long-acting
insulin, long-acting
---
http://www.has-sante.fr/portail/jcms/c_1738609/fr/tresiba
2014
false
false
false
France
French
evaluation of the transparency committee
injections, subcutaneous
hypoglycemic agents
hypoglycemic agents
insurance, health, reimbursement
adult
diabetes mellitus, type 1
diabetes mellitus, type 2
insulin degludec
insulin degludec
insulin degludec
treatment outcome
aged
clinical trials, phase iii as topic
meta-analysis as topic
guidelines for drug use
insulin, long-acting
insulin, long-acting
---
http://www.prescrire.org/Fr/3/31/49150/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
french abstract
cardiovascular risk
insulin
insulin degludec
pain
risk
---
https://www.ema.europa.eu/medicines/human/EPAR/Tresiba
2013
false
United Kingdom
French
English
insulin degludec
insulin, long-acting
insulin, long-acting
treatment outcome
drug approval
europe
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 1
diabetes mellitus, type 2
adult
injections, subcutaneous
summary of product characteristics
package leaflet
drug evaluation
syndication feed
recombinant proteins
aged
drug interactions
pregnancy
breast feeding
fertility
randomized controlled trials as topic
Glycated Hemoglobin
insulin degludec
insulin degludec
---
https://www.ema.europa.eu/medicines/human/EPAR/Ryzodeg
2013
false
United Kingdom
English
French
insulin degludec and insulin aspart
insulin degludec, insulin aspart drug combination
insulin degludec, insulin aspart drug combination
insulin aspart
drug combinations
drug approval
europe
treatment outcome
insulin, long-acting
insulin, long-acting
hypoglycemic agents
hypoglycemic agents
injections, subcutaneous
diabetes mellitus, type 1
diabetes mellitus, type 2
summary of product characteristics
package leaflet
drug evaluation
syndication feed
recombinant proteins
adult
aged
drug interactions
pregnancy
breast feeding
fertility
randomized controlled trials as topic
Glycated Hemoglobin
drug combinations
drug combinations
insulin aspart
insulin degludec
insulin degludec
---
